logo
  

Weyerhaeuser Hikes Dividend, To Buy Back $500 Mln Of Shares

Weyerhaeuser Co. (WY) announced that its board declared a dividend on the company's common shares of $0.31 per share, reflecting a 6.9 percent increase from the prior quarterly dividend of $0.29 per share. The dividend is payable in cash on September 25, 2015, to holders of record of such common shares at the close of business on September 11, 2015.

Additionally, the board has authorized a new share repurchase program of up to $500 million of the company's common shares. The new repurchase program commences upon completion of the existing $700 million share repurchase program authorized in 2014. As of June 30, 2015, the company had repurchased $610 million, or 87 percent, of its $700 million authorization.

The company's board of directors has also declared a dividend of $0.7969 per share on the company's 6.375% Mandatory Convertible Preference Shares, Series A, which will be payable in cash on October 1, 2015 to holders of record of such mandatory convertible preference shares at the close of business on September 15, 2015.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
While reporting financial results for the first quarter on Wednesday, medical devices company Boston Scientific Corp. (BSX) raised its adjusted earnings and net sales growth guidance for the full-year 2024. For fiscal 2024, the company now projects earnings in a range of $1.43 to $1.48 per share and... Shares of Roche Holding AG were losing around 3 percent in Switzerland after the drug major reported weak sales in its first quarter and confirmed fiscal 2024 outlook. Excluding COVID-19-related products, quarterly sales increasedy 7 percent. For fiscal 2024, Roche continues to expect an increase in group sales in the mid single digit range at constant exchange rates. Dr. Reddy's Laboratories Ltd. is recalling six lots of Sapropterin Dihydrochloride Powder for Oral Solution 100 mg to the consumer level. According to the U.S. Food and Drug Administration, the recall was due to powder discoloration in some packets leading to decreased potency.

This week, we feature Nigeria’s combat with meningitis, Hostile takeover bid for Vanda Pharma, US opioid crisis, Sammy’s Milk’s safety concerns, and X4’s Mavorixafor’s fast-track status.

View More Videos
RELATED NEWS
Follow RTT